Exploring the prevalence of gestational diabetes mellitus and associated factors among pregnant women attending tertiary antenatal hospitals in Bangladesh: a cross-sectional survey-based approach Authors: Mahmuda Tasnim, Nazifa Tabassum Tasnim, Aklima Sultana, Nadia Sultana Deen, Fahim Kabir Monjurul Haque Published: 2026 ABSTRACT BackgroundGestational diabetes mellitus (GDM) is a form of hyperglycemia which is first diagnosed during pregnancy. South Asian women show a higher prevalence of GDM, which has been associated with both genetic and lifestyle factors.ObjectivesThis survey-based cross-sectional study aimed to estimate the prevalence of GDM among pregnant women attending tertiary healthcare facilities for antenatal care and to identify factors independently associated with GDM.MethodsA total of 250 pregnant women at 18–40 weeks of gestation attending tertiary healthcare facilities in the Dhaka, Chattogram, and Mymensingh divisions were selected using a non-probability consecutive sampling approach. Data were collected using a structured questionnaire covering demographic, obstetric, clinical, and lifestyle factors after obtaining informed consent from all participants. GDM status was determined based on a one-step 75 g OGTT test in accordance with national and WHO criteria.ResultsThe prevalence of GDM was 14% in this study. Fisher’s exact test and Chi-square test were used for initial comparisons. Univariate and multivariate logistic regression were performed to estimate crude odds ratios (cOR) and adjusted odds ratios (aOR) with 95% confidence intervals (95% CI) for factors associated with GDM. In the adjusted analysis, obesity class II (aOR: 9.929, 95% CI: 1.174–83.983, p = 0.035) and obesity class III (aOR: 26.945, 95% CI: 1.101-659.624, p = 0.044) were significantly associated with increased odds of GDM. However, the wide confidence intervals suggest limited precision of these estimates. Parental history of diabetes (aOR: 3.079, 95% CI: 1.275–7.432, p = 0.012), betel quid chewing (aOR: 2.689, 95% CI: 1.010–7.160, p = 0.048), and sugar-sweetened beverage intake (aOR: 3.827, 95% CI: 1.649–8.880, p = 0.002) were also significantly associated with increased odds of GDM. In contrast, maternal age (aOR: 0.996, 95% CI: 0.911–1.088, p = 0.922), pre-obesity (aOR: 2.238, 95% CI: 0.461–10.864, p = 0.317), obesity class I (aOR: 4.515, 95% CI: 0.921–22.139, p = 0.063) and oral contraceptive use (aOR: 2.136, 95% CI: 0.871–5.240, p = 0.097) were not significantly associated with GDM after adjustment. The first pregnancy was associated with lower odds of GDM in the crude analysis; however, this association was no longer statistically significant after adjustment (aOR: 0.382, 95% CI: 0.118–1.241, p = 0.110).ConclusionThese findings highlight the multifactorial nature of GDM, with both genetic susceptibility and modifiable lifestyle behaviours contributing to its development. Targeted awareness initiatives focusing on dietary behaviours, particularly reducing the consumption of sugar-sweetened beverages, may be beneficial in similar populations, alongside early screening of women with a family history of diabetes.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12884-026-09358-w. Introduction Gestational diabetes mellitus (GDM) is a type of glucose intolerance that develops during pregnancy and is often diagnosed between the 24th and 28th weeks of gestation [1]. Insulin resistance and pregnancy-induced hormonal shifts play central roles, which closely mirror the pathophysiology of type 2 diabetes [2]. Globally, systematic estimates indicate that approximately 14% of pregnancies are affected by GDM [3]. According to the International Diabetes Federation in 2017, one in seven births worldwide was affected by GDM [4]. However, prevalence varies substantially across regions. In Bangladesh, GDM is an emerging public health concern, with a steadily increasing prevalence [5]. The development of GDM is influenced by various predisposing factors, which can be broadly classified into lifestyle, sociodemographic, obstetric, and clinical categories [6]. Uncontrolled GDM can trigger a cascade of adverse maternal and neonatal outcomes, with maternal sequelae characterized by vaginal infection [7], polyhydramnios [8], macrosomia, preterm birth, increased rate of cesarean section, and obstructed labor [9]. Neonatal complications may include hypoglycemia, neonatal jaundice, hypocalcemia, respiratory distress syndrome, and birth trauma [10], while long-term outcomes in offspring include increased likelihood of obesity, type 2 diabetes mellitus, rapid weight gain, and cardiovascular diseases in later life [11]. From a maternal health perspective, a history of GDM is associated with higher odds of recurrence in subsequent pregnancies, as well as an increased likelihood of developing type 2 diabetes and cardiovascular disease over time. These outcomes underscore the complexity of GDM and reinforce the need for comprehensive screening and interventions [12]. The study aimed to explore the factors associated with GDM, including sociodemographic, obstetric, clinical, and lifestyle determinants, to facilitate early identification of women at a higher likelihood of GDM. The findings may contribute to a better understanding of GDM prevalence and factors associated with GDM among participants attending tertiary antenatal hospitals and may help inform screening and prevention strategies. Materials and methods Study design and setting This hospital-based cross-sectional study was conducted among 250 consecutively recruited pregnant women attending tertiary antenatal care facilities in the Dhaka, Chattogram, and Mymensingh divisions of Bangladesh between March and September 2024. The study was conducted and reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines [13] (Table S.2). Study population, eligibility, and recruitment Pregnant women attending routine tertiary antenatal clinics were screened for eligibility. Informed written consent in both the local and English languages and institutional ethical approval were obtained before data collection. Inclusion criteria were gestational age between 18 and 40 weeks, and age ≥ 16 years. Participants were required to have undergone a one-step 75 g oral glucose tolerance test (OGTT) and had to provide written informed consent. Pregnant women who did not undergo the one-step 75 g OGTT or who refused to provide written informed consent were excluded from the study. All eligible participants during the study period were approached using a non-probability consecutive sampling method by trained research personnel. Enrollment continued until the required sample size was achieved. This approach aimed to reduce selection bias by ensuring systematic inclusion of all eligible participants. The diagnostic criteria for GDM were based on a one-step 75 g OGTT with three plasma glucose measurements obtained at fasting, 1 h, and 2 h, in accordance with Bangladesh government guidelines adapted from World Health Organization (WHO) recommendations [14]. Although routine screening is recommended between 24 and 28 weeks of gestation, early screening is performed for high-risk women [15]. All measurements were based on venous plasma glucose. GDM was diagnosed when any of these measured values met or exceeded the diagnostic threshold shown in Table 1. Table 1Diagnostic criteria for GDM in pregnancy [14]GDMFPG5.1-<7.0 mmol/L (92-<126 mg/dL)1-hr PG at OGTT≥ 10.0 mmol/L (180 mg/dL)2-hr PG at OGTT8.5-<11.1 mmol/L (153-<200 mg/dL)FPG Fasting plasma glucose, PG Plasma glucose, OGTT Oral glucose tolerance test Table 1Diagnostic criteria for GDM in pregnancy [14]GDMFPG5.1-<7.0 mmol/L (92-<126 mg/dL)1-hr PG at OGTT≥ 10.0 mmol/L (180 mg/dL)2-hr PG at OGTT8.5-<11.1 mmol/L (153-<200 mg/dL)FPG Fasting plasma glucose, PG Plasma glucose, OGTT Oral glucose tolerance test Diagnostic criteria for GDM in pregnancy [14] FPG Fasting plasma glucose, PG Plasma glucose, OGTT Oral glucose tolerance test Sample size justification The minimum sample size was calculated using a single-proportion formula based on an estimated GDM prevalence of 13% [16], with 95% confidence interval (95% CI), 5% margin of error, and 80% statistical power, resulting in a required sample size of 174 participants. The formula used for sample size estimation was as follows:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:n=\frac{{z}^{2}p\:(1-p)}{{e}^{2}}\:$$\end{document} z represents the standard normal variate at a confidence interval of 95% = 1.96. p is the prevalence = 13% [16], e represents the margin of error = 0.05. n is the minimum number of participants = \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\frac{\:1.962\:\left(0.13\right)\:(1-0.13)}{{\left(0.05\right)}^{2}\:}$$\end{document}. = 173.79. ≈ 174. To improve the precision of the prevalence estimate and provide a more adequate basis for exploratory multivariable regression analysis, the final sample size was increased to 250 participants. Data collection Questionnaire Data were collected using a structured interviewer-administered questionnaire with information verified from medical records where available. The components of the questionnaire aimed to evaluate sociodemographic factors, including age, educational qualifications, occupational status and marital status. The questionnaire also assessed the obstetric factors associated with GDM, including history of preeclampsia, pregnancy-related symptoms, and prior perinatal outcomes. Furthermore, the components were utilized to evaluate the clinical variables associated with GDM, including Body Mass Index (BMI), family history of diabetes and hypertension, and prior use of oral contraceptives. Lastly, the questionnaire evaluated lifestyle variables, including physical activity, chewing betel quid, and consumption of sugar-sweetened beverages and fast food. Variables Maternal age was analyzed as a continuous variable in the regression model, whereas all other sociodemographic, obstetric, clinical, and lifestyle variables were coded as categorical variables for statistical analysis. Anthropometric measurements Anthropometric data, including weight and height, were collected to calculate Body Mass Index (BMI). Height was measured using a stadiometer at enrolment. Pre-pregnancy weight was obtained through self-report. BMI was calculated using the formula: weight (Kg) divided by height (m2), and categorized according to WHO cut-offs adapted for Asian populations: underweight (< 18.5 Kg/m2), normal weight (18.5–24.9 Kg/m2), pre-obesity (25-29.9 Kg/m2 ), obesity class I (30-34.9 Kg/m2), obesity class II (35-39.9 Kg/m2), and obesity class III (≥ 40 Kg/m2) [17–19]. Lifestyle factors Lifestyle variables, including physical activity, betel quid chewing, sugar-sweetened beverage consumption, and fast-food intake, were self-reported and categorized as binary variables (Yes/No) according to regular engagement or consumption. Statistical analysis The collected data were organized in Microsoft Excel 2018, followed by statistical analysis using SPSS version 23.0 (Chicago, IL, USA) and GraphPad Prism version 8 to generate comprehensive statistical results. The study variables were summarized using descriptive statistics, where categorical variables were shown as frequencies and percentages. A bar chart was used to graphically depict the prevalence of GDM. Sociodemographic, obstetric, clinical, and lifestyle variables were first assessed using univariate logistic regression analysis to estimate crude odds ratios (cOR). Maternal age was modelled as a continuous variable (per 1-year increase). Variables with p-value < 0.05, along with those of established clinical relevance, were considered for inclusion in the multivariable logistic regression model to estimate adjusted odds ratios (aOR) with 95% CI. A p-value < 0.05 was considered statistically significant. All variables included in the analysis had complete data, with no missing values. Estimates affected by sparse data or zero cell counts were reported as “not estimated” in the table. Results Prevalence of GDM Among the 250 eligible pregnant women, 35 were diagnosed with GDM, resulting in a prevalence of 14%. The remaining 215 (86%) participants did not have GDM (Fig. 1). Fig. 1Prevalence of GDM among study participants. GDM: Gestational diabetes mellitus, No GDM: Participants without gestational diabetes mellitus Prevalence of GDM among study participants. GDM: Gestational diabetes mellitus, No GDM: Participants without gestational diabetes mellitus Characteristics of the study participants Sociodemographic, obstetric, clinical, and lifestyle characteristics of the study participants are presented as frequencies in Tables 2 and 3. Table 2Participant characteristicsVariableFrequency (n)Percentage (%)Age Category (Years) 16–2511445.6 26–308232.8 31–354317.2 36–40114.4Educational Level Class 5–84216.8 SSC4417.6 HSC9136.4 Honors4919.6 Masters249.6Marital Status Married250100 Unmarried00Occupational Status Yes5722.8 No19377.2BMI Before Pregnancy (Kg/m2) Underweight (< 18.5 Kg/m2)00 Normal Weight (18.5–24.9 Kg/m2)4919.6 Pre-obesity (25.0-29.9 Kg/m2)11445.6 Obesity Class I (30.0-34.9 Kg/m2)7630.4 Obesity Class II (35.0-39.9 Kg/m2)93.6 Obesity Class III (≥ 40 Kg/m2)20.8History of Diabetes Yes83.2 No24296.8Hypertension Yes208 No23092Additional Comorbidities Yes208 No23092Family History of Hypertension Father5722.8 Mother6224.8 Both3313.2 None9839.2Family History of Diabetes Father5321.2 Mother4216.8 Both3413.6 None12148.4Birth Control Methods Birth Control Implant00 Barrier Method: Condom4618.4 Emergency Contraception10.4 Oral Contraceptive Pill4518 None15863.2Antenatal Visit Frequency Monthly22088 Weekly3012GDM Yes3514 No21586Preeclampsia Yes2911.6 No22188.4Method of Conception Naturally19778.8 After Consulting with the Fertility Doctor5321.2First Pregnancy Yes6927.6 No18172.4GDM in Previous Pregnancy* Yes2314.1 No14085.9Term Delivery Full Term*8232.8 Early Delivery*7630.4Previous Delivery Status* Cesarean Section9839.2 Vaginal Delivery6224.8Cesarean Section due to GDM* Yes1878.3 No521.7Previous Complications* Induced Abortion135.2 Miscarriage due to Any Other Reason4819.2 IUFD83.2 Still Birth104 No Complications15160.4Miscarriage and IUFD due to GDM* Yes1221.43 No4478.57SSC Secondary school certificate, HSC Higher secondary school certificate, IUFD Intrauterine fetal demise*Only participants with previous pregnancy Table 2Participant characteristicsVariableFrequency (n)Percentage (%)Age Category (Years) 16–2511445.6 26–308232.8 31–354317.2 36–40114.4Educational Level Class 5–84216.8 SSC4417.6 HSC9136.4 Honors4919.6 Masters249.6Marital Status Married250100 Unmarried00Occupational Status Yes5722.8 No19377.2BMI Before Pregnancy (Kg/m2) Underweight (< 18.5 Kg/m2)00 Normal Weight (18.5–24.9 Kg/m2)4919.6 Pre-obesity (25.0-29.9 Kg/m2)11445.6 Obesity Class I (30.0-34.9 Kg/m2)7630.4 Obesity Class II (35.0-39.9 Kg/m2)93.6 Obesity Class III (≥ 40 Kg/m2)20.8History of Diabetes Yes83.2 No24296.8Hypertension Yes208 No23092Additional Comorbidities Yes208 No23092Family History of Hypertension Father5722.8 Mother6224.8 Both3313.2 None9839.2Family History of Diabetes Father5321.2 Mother4216.8 Both3413.6 None12148.4Birth Control Methods Birth Control Implant00 Barrier Method: Condom4618.4 Emergency Contraception10.4 Oral Contraceptive Pill4518 None15863.2Antenatal Visit Frequency Monthly22088 Weekly3012GDM Yes3514 No21586Preeclampsia Yes2911.6 No22188.4Method of Conception Naturally19778.8 After Consulting with the Fertility Doctor5321.2First Pregnancy Yes6927.6 No18172.4GDM in Previous Pregnancy* Yes2314.1 No14085.9Term Delivery Full Term*8232.8 Early Delivery*7630.4Previous Delivery Status* Cesarean Section9839.2 Vaginal Delivery6224.8Cesarean Section due to GDM* Yes1878.3 No521.7Previous Complications* Induced Abortion135.2 Miscarriage due to Any Other Reason4819.2 IUFD83.2 Still Birth104 No Complications15160.4Miscarriage and IUFD due to GDM* Yes1221.43 No4478.57SSC Secondary school certificate, HSC Higher secondary school certificate, IUFD Intrauterine fetal demise*Only participants with previous pregnancy Participant characteristics SSC Secondary school certificate, HSC Higher secondary school certificate, IUFD Intrauterine fetal demise *Only participants with previous pregnancy Table 3Baseline characteristics of lifestyle factorsVariablesFrequency (n)Percentage (%)Physical Activities Yes7329.2 No17770.8Chewing Betel Quid Betel leaf124.8 Areca nuts114.4 Zarda83.2 Betel Leaf and Areca Nuts31.2 Betel Leaf, Areca Nuts and Zarda31.2 None21385.5Smoking Yes00 No250100Change of Diet Yes21987.6 No3112.4Regular Intake of Fruit and Vegetables Yes24196.4 No93.6Snacks Between Meals Yes24798.8 No31.2Sugar-Sweetened Beverage Intake Yes7028 No18072Fast Food Intake Yes6124.4 No18975.6 Table 3Baseline characteristics of lifestyle factorsVariablesFrequency (n)Percentage (%)Physical Activities Yes7329.2 No17770.8Chewing Betel Quid Betel leaf124.8 Areca nuts114.4 Zarda83.2 Betel Leaf and Areca Nuts31.2 Betel Leaf, Areca Nuts and Zarda31.2 None21385.5Smoking Yes00 No250100Change of Diet Yes21987.6 No3112.4Regular Intake of Fruit and Vegetables Yes24196.4 No93.6Snacks Between Meals Yes24798.8 No31.2Sugar-Sweetened Beverage Intake Yes7028 No18072Fast Food Intake Yes6124.4 No18975.6 Baseline characteristics of lifestyle factors Sociodemographic and clinical characteristics Sociodemographic and clinical characteristics of the participants are presented in Table 2. A total of 250 pregnant women were included in the final analysis. Nearly half (45.6%) were aged 16–25 years, while 4.4% were aged 36–40 years. Regarding educational attainment, 42 (16.8%) participants had primary-level education. In terms of occupational status, the majority were homemakers, while 22.8% were engaged in paid employment. Regarding clinical history, 48.4% reported no family history of diabetes, while 13.6% reported both parental diabetes. In addition, 39.2% reported no family history of hypertension. In relation to contraceptive use, 63.2% reported no prior use, while barrier methods were the most common among users, followed by oral contraceptives (18%). Notably, the majority (96.8%) of the participants had no personal history of diabetes, and 92.0% had no history of hypertension (Table 2). Obstetric characteristics of the participants In the current pregnancy, based on a one-step 75 g OGTT, 14% were diagnosed with GDM, while 11.6% were diagnosed with preeclampsia. Additionally, 14.1% of the participants reported having GDM in the previous pregnancy. Further, among the study participants, 27.6% were in their first pregnancy, while the majority (72.4%) had experienced at least one pregnancy. Among those with prior deliveries, 39.2% underwent cesarean section, while 24.8% had vaginal delivery. Among participants with a previous history of GDM, 78.3% (18/23) reported having undergone a cesarean section in a prior pregnancy. Regarding pregnancy loss, 5.2% of the participants experienced induced abortion, 19.2% reported miscarriage, and 3.2% experienced intrauterine fetal demise (IUFD). In addition to that, 4% had a history of stillbirth (Table 2). Lifestyle factors In terms of lifestyle habits (Table 3), only 29.2% of the participants reported engaging in regular exercise. Notably, 85.5% did not chew betel quid. Moreover, 98.8% of participants reported consuming snacks between meals, while 96.4% reported regular consumption of fruits and vegetables. Additionally, 28% and 24.4% of participants reported regular consumption of sugar-sweetened beverages and fast food, respectively. Multivariable logistic regression analysis of factors associated with GDM Full unadjusted analysis for all screened variables is presented in the supplementary file (Table S.1). Table 4 presents the final multivariable logistic regression model, including variables considered suitable for adjusted analysis. Table 4Multivariable logistic regression analysis of factors associated with GDMVariablecOR (95% CI)p-value (Crude)aOR (95% CI)p-value (Adjusted)Maternal age (Continuous-Per 1-Year Increase) Maternal age1.036 (0.967–1.109)0.3200.996(0.911–1.088)0.922Pre-Pregnancy BMI (Categorical-Reference: Normal 18.5–24.9 Kg/m2) Underweight (< 18.5 Kg/m2)NE-NE - Normal (18.5–24.9 Kg/m2)Ref (1) - Ref (1) - Pre-obesity (25-29.9 Kg/m2)3.025(0.656–13.947)0.1562.238(0.461–10.864)0.317 Obesity Class I (30-34.9 Kg/m2)6.267(1.372–28.617)0.0184.515(0.921–22.139)0.063 Obesity Class II (35-39.9 Kg/m2)11.750(1.621–85.165)0.0159.929(1.174–83.983)0.035 Obesity Class III (≥ 40 Kg/m2)23.500(1.046-528.051)0.04726.945(1.101-659.624)0.044Covariates One or Both Parental Diabetes (Yes vs. No)3.141(1.406–7.018)0.0053.079(1.275–7.432)0.012 First Pregnancy (Yes vs. No)0.293(0.109–0.785)0.0150.382(0.118–1.241)0.110 Oral Contraceptive Use (Yes vs. No)2.984(1.351–6.591)0.0072.136(0.871–5.240)0.097 Betel Quid Chewing (Yes vs. No)2.374(1.039–5.424)0.0402.689(1.010–7.160)0.048 Sugar-Sweetened Beverage Intake (Yes vs. No)3.319(1.595–6.906)0.0013.827(1.649–8.880)0.002cOR Crude odds ratios, aOR Adjusted odds ratios, CI Confidence interval, Ref Reference categoryA p-value < 0.05 was considered statistically significant. Maternal age was modelled as a continuous variable (per 1-year increase). Pre-pregnancy BMI was categorized according to standard clinical cut-offs, with normal weight (18.5–24.9 Kg/m2) as the reference groupNE = Not estimated due to sparse data or insufficient variation between groups Table 4Multivariable logistic regression analysis of factors associated with GDMVariablecOR (95% CI)p-value (Crude)aOR (95% CI)p-value (Adjusted)Maternal age (Continuous-Per 1-Year Increase) Maternal age1.036 (0.967–1.109)0.3200.996(0.911–1.088)0.922Pre-Pregnancy BMI (Categorical-Reference: Normal 18.5–24.9 Kg/m2) Underweight (< 18.5 Kg/m2)NE-NE - Normal (18.5–24.9 Kg/m2)Ref (1) - Ref (1) - Pre-obesity (25-29.9 Kg/m2)3.025(0.656–13.947)0.1562.238(0.461–10.864)0.317 Obesity Class I (30-34.9 Kg/m2)6.267(1.372–28.617)0.0184.515(0.921–22.139)0.063 Obesity Class II (35-39.9 Kg/m2)11.750(1.621–85.165)0.0159.929(1.174–83.983)0.035 Obesity Class III (≥ 40 Kg/m2)23.500(1.046-528.051)0.04726.945(1.101-659.624)0.044Covariates One or Both Parental Diabetes (Yes vs. No)3.141(1.406–7.018)0.0053.079(1.275–7.432)0.012 First Pregnancy (Yes vs. No)0.293(0.109–0.785)0.0150.382(0.118–1.241)0.110 Oral Contraceptive Use (Yes vs. No)2.984(1.351–6.591)0.0072.136(0.871–5.240)0.097 Betel Quid Chewing (Yes vs. No)2.374(1.039–5.424)0.0402.689(1.010–7.160)0.048 Sugar-Sweetened Beverage Intake (Yes vs. No)3.319(1.595–6.906)0.0013.827(1.649–8.880)0.002cOR Crude odds ratios, aOR Adjusted odds ratios, CI Confidence interval, Ref Reference categoryA p-value < 0.05 was considered statistically significant. Maternal age was modelled as a continuous variable (per 1-year increase). Pre-pregnancy BMI was categorized according to standard clinical cut-offs, with normal weight (18.5–24.9 Kg/m2) as the reference groupNE = Not estimated due to sparse data or insufficient variation between groups Multivariable logistic regression analysis of factors associated with GDM 0.996 (0.911–1.088) 3.025 (0.656–13.947) 2.238 (0.461–10.864) 6.267 (1.372–28.617) 4.515 (0.921–22.139) 11.750 (1.621–85.165) 9.929 (1.174–83.983) 23.500 (1.046-528.051) 26.945 (1.101-659.624) 3.141 (1.406–7.018) 3.079 (1.275–7.432) 0.293 (0.109–0.785) 0.382 (0.118–1.241) 2.984 (1.351–6.591) 2.136 (0.871–5.240) 2.374 (1.039–5.424) 2.689 (1.010–7.160) 3.319 (1.595–6.906) 3.827 (1.649–8.880) cOR Crude odds ratios, aOR Adjusted odds ratios, CI Confidence interval, Ref Reference category A p-value < 0.05 was considered statistically significant. Maternal age was modelled as a continuous variable (per 1-year increase). Pre-pregnancy BMI was categorized according to standard clinical cut-offs, with normal weight (18.5–24.9 Kg/m2) as the reference group NE = Not estimated due to sparse data or insufficient variation between groups Discussion Our findings indicate a GDM prevalence of 14% (35/250 participants), which closely aligns with the 13% prevalence reported in a recent systematic review from Bangladesh [20] and is consistent with the global estimate of approximately 14% reported by the IDF Diabetes Atlas [21]. This suggests that the burden of GDM in the current cohort is broadly comparable to pooled regional estimates despite differences in study design, setting, and population characteristics. Maternal age was not significantly associated with GDM in the crude analysis (cOR: 1.036, 95% CI: 0.967–1.109, p = 0.320), and this finding remained non-significant after adjustment for key covariates (aOR: 0.996, 95% CI: 0.911–1.088, p = 0.922). The lack of a significant association may reflect the predominantly young age distribution of the sample, with nearly half of the participants (45.6%) aged 16–25 years, which may have limited the ability to detect an age-related effect. In contrast, the broader epidemiological literature consistently reports an association between advanced maternal age and GDM [22]. The discrepancy may therefore be attributable to the characteristics of the present study sample, particularly the limited representation of older maternal age groups. Pre-pregnancy BMI was modelled as a categorical variable using established WHO clinical thresholds, with normal weight (18.5–24.9 Kg/m²) as the reference category. In the crude analysis, increasing BMI categories were associated with higher odds of GDM, particularly among women with obesity. After adjustment for relevant covariates, this increasing trend persisted. Although pre-obesity and obesity class I showed elevated estimates, these were not statistically significant, whereas obesity class II and class III were significantly associated with higher odds of GDM. These findings suggest a possible dose-response pattern between increasing maternal adiposity and GDM. Similar patterns have been reported in previous studies, where higher pre-pregnancy BMI has been consistently linked to higher odds of GDM [23]. However, the wide confidence intervals observed in the higher BMI categories indicate limited precision, likely reflecting small sample sizes within these groups. Therefore, these findings should be interpreted with caution. A parental history of diabetes (one or both parents) was strongly associated with GDM in both crude and adjusted analyses, indicating a possible contribution of genetic susceptibility and shared metabolic factors. This finding is consistent with previous studies highlighting parental diabetes as a factor associated with GDM [24, 25]. Women experiencing their first pregnancy (primigravida status) had significantly lower odds of GDM in the crude analysis; however, this association did not remain statistically significant after adjustment for potential confounders. Although prior studies have reported lower odds of GDM among primigravid women, this was not observed in the adjusted model. The initial difference may reflect underlying variations between primigravid and multiparous women, including younger maternal age and lower cumulative metabolic burden. In contrast, increasing parity has been associated with metabolic changes and higher insulin resistance [26]. Regarding hormonal exposure, oral contraceptive use was associated with increased odds of GDM in the unadjusted analysis; this relationship was attenuated after adjustment for potential confounders. This suggests that the initial association may reflect underlying metabolic or lifestyle characteristics rather than an independent effect. Previous studies have reported that oral contraceptives may influence glucose metabolism and insulin sensitivity, which could partly explain the association observed in the unadjusted analysis [27]. Among lifestyle-related exposures, the intake of sugar-sweetened beverages was independently associated with GDM in the adjusted analysis. This association is supported by prior studies linking sugar-sweetened beverages to impaired glucose metabolism and insulin resistance [28, 29]. The relatively large effect size emphasizes the potential role of this exposure as a modifiable factor. Given the increasing consumption of sugar-sweetened beverages in Bangladesh, these findings may have important implications for antenatal dietary guidance and public health interventions. Additionally, betel quid chewing was associated with higher odds of GDM in crude and adjusted analyses. Although direct evidence linking betel quid chewing specifically to GDM is limited, studies from Bangladesh have reported associations with type 2 diabetes, which may reflect underlying effects on glucose regulation [30, 31]. However, the relatively wide confidence interval observed in the adjusted analysis indicates limited precision; therefore, the estimates should be interpreted with caution. An association between GDM and vaginal discharge was observed and should be interpreted with caution. Women with GDM reported a higher frequency of vaginal discharge compared to those without GDM. This may reflect alterations in the vaginal environment associated with hyperglycemia, which can disrupt vaginal pH and influence vaginal flora, potentially increasing susceptibility to infection [32]. This finding is presented in the supplementary file (Figure S.1). Limitations and generalizability The current study has several limitations that should be considered when interpreting the findings. Firstly, the hospital-based, cross-sectional study design, employing non-probability consecutive sampling in a tertiary antenatal setting, limits the generalizability of the prevalence estimate to the broader population of pregnant women in Bangladesh. Women attending tertiary hospitals may differ systematically from the general population, including exhibiting higher health-seeking behaviours and a greater burden of pregnancy-related complications, which may introduce selection bias and potentially overestimate the prevalence of GDM. Secondly, several exposures, including lifestyle factors, contraceptive use, family history, and vaginal discharge, were self-reported and were therefore subject to recall bias and social desirability bias. Thirdly, some subgroups, particularly women with a previous history of GDM, were small, resulting in imprecise estimates and wide confidence intervals. Despite efforts to minimize overfitting and sparse data bias in the multivariable analysis, residual confounding cannot be entirely ruled out due to the observational nature of the study. In terms of generalizability, the findings are particularly relevant to pregnant women attending urban and peri-urban tertiary healthcare facilities in Bangladesh. Caution is needed when extrapolating these results to women in primary care settings, rural areas, or those with limited access to antenatal services. In contrast to findings from a substantial body of international literature identifying advanced maternal age and previous obstetric history as important factors associated with GDM, some of these variables were not retained in the adjusted model. This discrepancy may be explained by the limited representation of these subgroups, which likely reduced the statistical power to detect independent effects. Therefore, these findings should not be interpreted as contradicting established epidemiological findings. Overall, the present study highlights the multifactorial nature of GDM, with metabolic and lifestyle-related factors appearing particularly important in this population. These findings underscore the potential value of targeted health interventions, focusing on weight management, screening of family history and reducing sugar-sweetened beverage consumption. Supplementary Information Supplementary Material 1. Supplementary Material 1.